vs
Cytek Biosciences, Inc.（CTKB）与Eventbrite, Inc.（EB）财务数据对比。点击上方公司名可切换其他公司
Eventbrite, Inc.的季度营收约是Cytek Biosciences, Inc.的1.2倍（$73.5M vs $62.1M），Eventbrite, Inc.净利率更高（-11.1% vs -70.9%，领先59.8%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -3.9%），Cytek Biosciences, Inc.自由现金流更多（$-1.8M vs $-60.9M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs -7.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
Eventbrite是源自美国的线下活动服务平台，为用户提供活动浏览、创建与推广服务，支持主办方免费在平台发布不限规模、不限数量的各类活动，是全球范围内活跃度较高的活动交易与推广平台。
CTKB vs EB — 直观对比
营收规模更大
EB
是对方的1.2倍
$62.1M
营收增速更快
CTKB
高出12.0%
-3.9%
净利率更高
EB
高出59.8%
-70.9%
自由现金流更多
CTKB
多$59.1M
$-60.9M
两年增速更快
CTKB
近两年复合增速
-7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $73.5M |
| 净利润 | $-44.1M | $-8.2M |
| 毛利率 | 52.9% | 68.1% |
| 营业利润率 | -9.0% | -12.4% |
| 净利率 | -70.9% | -11.1% |
| 营收同比 | 8.1% | -3.9% |
| 净利润同比 | -557.1% | 2.5% |
| 每股收益（稀释后） | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBEB
| Q4 25 | $62.1M | $73.5M | ||
| Q3 25 | $52.3M | $71.7M | ||
| Q2 25 | $45.6M | $72.8M | ||
| Q1 25 | $41.5M | $73.8M | ||
| Q4 24 | $57.5M | $76.5M | ||
| Q3 24 | $51.5M | $77.8M | ||
| Q2 24 | $46.6M | $84.6M | ||
| Q1 24 | $44.9M | $86.3M |
净利润CTKBEB
| Q4 25 | $-44.1M | $-8.2M | ||
| Q3 25 | $-5.5M | $6.4M | ||
| Q2 25 | $-5.6M | $-2.1M | ||
| Q1 25 | $-11.4M | $-6.6M | ||
| Q4 24 | $9.6M | $-8.4M | ||
| Q3 24 | $941.0K | $-3.8M | ||
| Q2 24 | $-10.4M | $1.1M | ||
| Q1 24 | $-6.2M | $-4.5M |
毛利率CTKBEB
| Q4 25 | 52.9% | 68.1% | ||
| Q3 25 | 52.7% | 67.9% | ||
| Q2 25 | 52.3% | 67.5% | ||
| Q1 25 | 48.6% | 66.9% | ||
| Q4 24 | 58.5% | 68.2% | ||
| Q3 24 | 56.3% | 68.5% | ||
| Q2 24 | 54.6% | 70.9% | ||
| Q1 24 | 51.3% | 71.0% |
营业利润率CTKBEB
| Q4 25 | -9.0% | -12.4% | ||
| Q3 25 | -17.6% | -1.3% | ||
| Q2 25 | -23.3% | -8.7% | ||
| Q1 25 | -36.1% | -13.2% | ||
| Q4 24 | 5.2% | -10.2% | ||
| Q3 24 | -8.2% | -11.5% | ||
| Q2 24 | -18.3% | -7.6% | ||
| Q1 24 | -23.9% | -8.8% |
净利率CTKBEB
| Q4 25 | -70.9% | -11.1% | ||
| Q3 25 | -10.5% | 8.9% | ||
| Q2 25 | -12.2% | -2.9% | ||
| Q1 25 | -27.5% | -9.0% | ||
| Q4 24 | 16.8% | -11.0% | ||
| Q3 24 | 1.8% | -4.8% | ||
| Q2 24 | -22.4% | 1.3% | ||
| Q1 24 | -13.8% | -5.2% |
每股收益（稀释后）CTKBEB
| Q4 25 | — | $-0.08 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $299.9M |
| 总债务越低越好 | — | $144.4M |
| 股东权益账面价值 | $341.7M | $179.1M |
| 总资产 | $461.5M | $647.2M |
| 负债/权益比越低杠杆越低 | — | 0.81× |
8季度趋势，按日历期对齐
现金及短期投资CTKBEB
| Q4 25 | $90.9M | $299.9M | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | $441.5M | ||
| Q3 24 | $162.3M | $24.7M | ||
| Q2 24 | $177.9M | $56.7M | ||
| Q1 24 | $168.8M | $113.7M |
总债务CTKBEB
| Q4 25 | — | $144.4M | ||
| Q3 25 | — | $174.9M | ||
| Q2 25 | — | $241.3M | ||
| Q1 25 | — | $241.0M | ||
| Q4 24 | — | $240.7M | ||
| Q3 24 | — | $240.4M | ||
| Q2 24 | — | $358.7M | ||
| Q1 24 | — | $358.2M |
股东权益CTKBEB
| Q4 25 | $341.7M | $179.1M | ||
| Q3 25 | $378.6M | $189.1M | ||
| Q2 25 | $377.6M | $177.2M | ||
| Q1 25 | $379.6M | $173.3M | ||
| Q4 24 | $395.7M | $170.2M | ||
| Q3 24 | $385.5M | $179.8M | ||
| Q2 24 | $389.1M | $176.2M | ||
| Q1 24 | $392.6M | $184.1M |
总资产CTKBEB
| Q4 25 | $461.5M | $647.2M | ||
| Q3 25 | $494.9M | $744.6M | ||
| Q2 25 | $493.3M | $784.1M | ||
| Q1 25 | $482.6M | $812.3M | ||
| Q4 24 | $499.5M | $752.3M | ||
| Q3 24 | $491.2M | $817.4M | ||
| Q2 24 | $483.7M | $894.5M | ||
| Q1 24 | $492.1M | $952.2M |
负债/权益比CTKBEB
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.39× | ||
| Q4 24 | — | 1.41× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 2.04× | ||
| Q1 24 | — | 1.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $-60.8M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-60.9M |
| 自由现金流率自由现金流/营收 | -2.9% | -82.8% |
| 资本支出强度资本支出/营收 | 1.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $17.6M |
8季度趋势，按日历期对齐
经营现金流CTKBEB
| Q4 25 | $-771.0K | $-60.8M | ||
| Q3 25 | $-3.9M | $36.7M | ||
| Q2 25 | $108.0K | $-17.5M | ||
| Q1 25 | $-125.0K | $59.4M | ||
| Q4 24 | $2.0M | $-45.3M | ||
| Q3 24 | $13.2M | $44.6M | ||
| Q2 24 | $6.2M | $-32.3M | ||
| Q1 24 | $4.0M | $68.6M |
自由现金流CTKBEB
| Q4 25 | $-1.8M | $-60.9M | ||
| Q3 25 | $-4.6M | $36.6M | ||
| Q2 25 | $-1.5M | $-17.5M | ||
| Q1 25 | $-974.0K | $59.4M | ||
| Q4 24 | $1.1M | $-45.3M | ||
| Q3 24 | $12.2M | $44.4M | ||
| Q2 24 | $5.2M | $-32.4M | ||
| Q1 24 | $3.4M | $68.2M |
自由现金流率CTKBEB
| Q4 25 | -2.9% | -82.8% | ||
| Q3 25 | -8.7% | 51.1% | ||
| Q2 25 | -3.2% | -24.1% | ||
| Q1 25 | -2.3% | 80.4% | ||
| Q4 24 | 1.9% | -59.2% | ||
| Q3 24 | 23.7% | 57.1% | ||
| Q2 24 | 11.0% | -38.3% | ||
| Q1 24 | 7.6% | 79.1% |
资本支出强度CTKBEB
| Q4 25 | 1.6% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 3.5% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 0.0% | ||
| Q3 24 | 2.0% | 0.2% | ||
| Q2 24 | 2.3% | 0.1% | ||
| Q1 24 | 1.3% | 0.4% |
现金转化率CTKBEB
| Q4 25 | — | — | ||
| Q3 25 | — | 5.76× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | -30.37× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
EB
| US | $52.0M | 71% |
| Other | $21.6M | 29% |
